Parabilis Medicines, Inc. Payments of Debt Issuance Costs
Parabilis Medicines, Inc. (PBLS) reported Payments of Debt Issuance Costs of $7.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-13
- 2026-06-30: Payments of Debt Issuance Costs 6 month $7.50M.
- 2025-06-30: Payments of Debt Issuance Costs 6 month $0.00.
| Period end | Payments of Debt Issuance Costs 6 month |
|---|---|
| 2026-06-30 | $7.50M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 |